Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | 130,00 € | 140,60 € | 8,16 % |
| United Therapeutics | 19 | 0 | 4 | 0 | 255,80 € | 287,40 € | 12,35 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 18,89 € | 26,01 € | 37,71 % |
| PTC Therapeutics Inc. | 15 | 7 | 3 | 2 | 35,20 € | 41,81 € | 18,79 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | 40,65 € | 47,17 € | 16,04 % |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | 8,75 € | 17,78 € | 103,19 % |
| Medpace Holdings Inc | 9 | 0 | 2 | 0 | 361,30 € | 421,61 € | 16,69 % |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | 22,83 € | 52,03 € | 127,88 % |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | 138,25 € | 236,30 € | 70,92 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 2 | 0 | 37,40 € | 84,74 € | 126,59 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 22,00 € | 32,58 € | 48,09 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 146,90 € | 184,76 € | 25,77 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 94,78 € | - | - |
| Iovance Biotherapeutics Inc. | 20 | 3 | 1 | 0 | 9,51 € | 22,78 € | 139,59 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | 31,40 € | 38,99 € | 24,17 % |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | 201,40 € | 248,57 € | 23,42 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 20,65 € | - | - |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | 4,55 € | 4,62 € | 1,54 % |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,55 € | 3,70 € | 138,71 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 50,56 € | 55,00 € | 8,78 % |